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Naïve T cells are relatively quiescent cells that only require energy to prevent atrophy
and for survival and migration. However, in response to developmental or extrinsic cues
T cells can engage in rapid growth and robust proliferation, produce of a range of effec-
tor molecules and migrate through peripheral tissues. To meet the signiﬁcantly increased
metabolic demands of these activities,T cells switch from primarily metabolizing glucose to
carbon dioxide through oxidative phosphorylation to utilizing glycolysis to convert glucose
to lactate (termed aerobic glycolysis). This metabolic switch allows glucose to be used as
a source of carbon to generate biosynthetic precursors for the production of protein, DNA,
and phospholipids, and is crucial for T cells to meet metabolic demands. Phosphoinositide
3-kinases (PI3K) are a family of inositol lipid kinases linked with a broad range of cellular
functions in T lymphocytes that include cell growth, proliferation, metabolism, differenti-
ation, survival, and migration. Initial research described a critical role for PI3K signaling
through Akt (also called protein kinase B) for the increased glucose uptake and glycolysis
that accompanies T cell activation. This review article relates this original research with
more recent data and discusses the evidence for and against a role for PI3K in regulating
the metabolic switch to aerobic glycolysis in T cells.
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PI3K IN T CELLS
Class 1 phosphoinositide 3-kinases (PI3K), lipid kinases that phos-
phorylate phosphatidylinositol-(4,5)-bisphosphate [PI(4,5)P2] to
generate the lipid signalingmolecule phosphatidylinositol-(3,4,5)-
trisphosphate [PI(3,4,5)P3], play a crucial role in many aspects
of T cell biology (Okkenhaug and Vanhaesebroeck, 2003). Class
1 PI3Ks consist of a catalytic subunit, responsible for the lipid
kinase activity, and an adapter subunit which links the catalytic
subunit to upstream activating signals. They are subdivided into
Class 1A; p110α, β, or δ catalytic subunits coupled to p85 adapter
subunits, and Class 1B; p110γ catalytic subunit coupled to the
p101 adapter protein. The p85 subunit couples Class 1A PI3Ks to
docking sites created by tyrosine-kinase signaling while the Class
IB p101 links the p110γ kinase with G-protein-coupled recep-
tors (Vanhaesebroeck et al., 2010). The levels of the lipid signaling
molecule PI(3,4,5)P3 are coordinately regulated by both class 1
PI3Ks and by the action of 3′ and 5′ phosphatases PTEN and
SHIP1 that dephosphorylate PI(3,4,5)P3to generate PI(4,5)P2 and
PI(3,4)P2 respectively (Figure 1A).
PI(3,4,5)P3 is an important lipid signaling molecule in T
cells, present at low levels in naïve T cells and elevated in
response to signaling initiated by the T cell receptor (TCR)
and various cytokine and chemokine receptors (Koyasu, 2003).
Following TCR engagement by antigen presenting cells (APC)
levels of PI(3,4,5)P3 accumulate in the plasma membrane and
are maintained for prolonged periods, requiring continual TCR
engagement and activation of PI3K (Costello et al., 2002; Har-
riague and Bismuth, 2002; Huppa et al., 2003). Signals from co-
stimulatory molecules such as CD28 are important for sustaining
PI(3,4,5)P3 levels following TCR engagement but are not in them-
selves sufﬁcient to stimulate PI3K as PI(3,4,5)P3 levels are only
induced when the TCR engages APC presenting cognate pep-
tide antigen (Costello et al., 2002; Garcon et al., 2007). Other
physiological stimuli that can stimulate PI(3,4,5)P3 levels in T
cells include cytokines and chemokines (Koyasu, 2003). While
PI(3,4,5)P3 levels are induced by a number of cytokines it
should be noted that the potency of these different cytokines
can vary, e.g., IL2 maintains high levels of PI(3,4,5)P3 while
IL15 maintains comparatively low levels (Cornish et al., 2006;
Sinclair et al., 2008).
In the thymus, PI3Kδ and PI3Kγ are the major isoforms
required in developing thymocytes. While deletion of PI3Kδ or γ
individually does not have a pronounced effect on thymopoiesis,
deletion or inactivation of both isoforms in developing T cells
results in a block early in thymocyte development at the CD4 CD8
double negative (DN) stage (Sasaki et al., 2000; Okkenhaug et al.,
2002; Webb et al., 2005; Swat et al., 2006; Ji et al., 2007). Negative
regulation of PI(3,4,5)P3 signaling is also important in developing
thymocytes. Thus, deletion of PTEN in early thymocyte progen-
itors results in constitutive PI(3,4,5)P3 signaling that leads to the
development of T cell leukemia or lymphoma (Suzuki et al., 2001;
Hagenbeek and Spits, 2008; Finlay et al., 2009). In contrast to
developing thymocytes, in mature T cells PI3Kδ appears to be the
major PI3K isoform responsible for promoting PI(3,4,5)P3 signal-
ing in activated T cells. Thus, a point mutation that makes p110δ
catalytically inactive (D910A) abolishes PI(3,4,5)P3 signaling in
activated T cell subsets (Okkenhaug et al., 2002, 2006; Macintyre
et al., 2011).
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FIGURE 1 | PI3K andAkt signaling. (A) PI(4,5)P2 is phosphorylated by
Class 1 PI3K isoforms generating the second messenger molecule
PI(3,4,5)P3. Levels of PI(3,4,5)P3 are negatively regulated by the lipid
phosphatases PTEN and SHIP. Binding of the PH domain of Akt to PI(3,4,5)P3
in the membrane results in a conformational change that allows for the
phosphorylation of Akt on key residues(T308 and S473) by PDK1 and
mTORC2. The recruitment of PDK1, via its PH domain, to the site of
PI(3,4,5)P3 is required for efﬁcient Akt activation. (B) Active Akt
phosphorylates Foxo transcription factors on multiple sites resulting in
their translocation to the cytoplasm where they are retained in complex
with 14-3-3 proteins. mTORC1 can be activated downstream of Akt, though
this does not occur in all T cell types. (C) PDK1 also phosphorylates and
activates a number of other members of the AGC kinase family in a PI3K
independent manner.
PI3K SIGNALING
PI(3,4,5)P3 acts as a signaling molecule through its interaction
with the pleckstrin homology (PH) domains of a diverse array
of signal transduction proteins. These proteins include Akt (also
called PKB), Tec family kinases, and guanine-nucleotide-exchange
proteins for Rho family GTPases. This interaction primarily con-
trols the subcellular localization of PHdomain containing proteins
but can also control protein conformation and enzyme activity.
Consider, for example, the activation of Akt, which is the best
characterized PI(3,4,5)P3 effector in T cells (for reviews Alessi
and Cohen, 1998; Hanada et al., 2004; Cameron et al., 2007). The
interaction of PI(3,4,5)P3 with the PH domain of Akt stimu-
lates its kinase activity by inducing a conformational change that
allows Akt to be phosphorylated on threonine 308 and serine 473
by its upstream activating kinases phosphoinositide-dependent
kinase 1 (PDK1) and mechanistic Target Of Rapamycin Complex
2 (mTORC2) respectively (Figure 1A; Calleja et al., 2007). PDK1
also contains a PHdomain and co-localization of Akt and PDK1 to
sites of PI(3,4,5)P3 is required for efﬁcientAkt activation (Bayascas
et al., 2008; Waugh et al., 2009). Once activated, Akt phosphory-
lates a number of important signaling molecules including the
Foxo transcription factors (Manning and Cantley, 2007). Foxo
transcription factors localize to the nucleus where they promote
the expression of target genes. Once phosphorylated by Akt,
Foxos translocate into the cytoplasm where they are retained
through their interaction with 14-3-3 proteins (Figure 1B;
Coffer and Burgering, 2004; Burgering, 2008). PI3K/Akt signaling
also activates the mTOR Complex 1 (mTORC1) in many cellu-
lar systems through multiple mechanisms (Laplante and Sabatini,
2009). mTORC1 is an important regulator of cellular metabolism
that senses environmental cues such as nutrient availability and
energy homeostasis (Delgoffe and Powell, 2009). However, it is
now becoming apparent that mTORC1 activity is not universally
dependent upon PI3K/Akt signaling in T cells. Thus, in activated
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CD8 cells, mTORC1 activity is not blocked by the disruption
of PI3K/Akt signaling by various pharmacological and genetic
strategies (unpublished data; Macintyre et al., 2011).
MATCHING GLUCOSE METABOLISM TO
METABOLIC DEMANDS
While naïve T cells only require energy to prevent atrophy and
for survival and migration, activated T cell subsets have a greatly
increased metabolic demand as they engage in rapid growth and
proliferation, and the production of cytokines and other effec-
tor molecules. It is crucial that activated T cells increase their
metabolism to meet the biosynthetic needs of the T cell as it
responds either to developmental or pathogenic cues. To achieve
this T cells respond to extrinsic signals from antigen receptors and
cytokines to up-regulate the surface expression of key nutrient
receptors: amino acid transporters, the transferrin receptor, and
glucose transporters (Fox et al., 2005a; Kelly et al., 2007; Jacobs
et al., 2008). Additionally, T cells switch their glucose metabolism
from oxidative phosphorylation to aerobic glycolysis; i.e., glucose
is metabolized to produce lactate even though oxygen is read-
ily available (Figure 2; Greiner et al., 1994). Aerobic glycolysis is
an inefﬁcient route to generating ATP, producing two molecules
ATP per molecule of glucose compared to >30 molecules ATP per
glucose generated by oxidative phosphorylation. Therefore, cells
must be able to sustain high levels of glucose uptake and an ele-
vated glycolytic ﬂux to generate sufﬁcient ATP. This is achieved
by increasing the expression of the GLUT1 glucose transporter
and certain rate limiting enzymes within the glycolytic path-
way (Vander Heiden et al., 2009; Marko et al., 2010). However,
the real advantage of switching from oxidative phosphorylation
to glycolysis is that it allows glucose to be used as a source
of carbon to generate nucleic acid, amino acids and phospho-
lipids (Figure 2; Vander Heiden et al., 2009). The generation of
these biosynthetic precursors is critical for cells engaging in rapid
growth, proliferation, and the synthesis of effector molecules.
Therefore, to facilitate their differentiation and function, acti-
vated T cells up-regulate the expression of GLUT1, increase
glucose uptake, and activate the switch to aerobic glycolysis
FIGURE 2 | PI3K controls the metabolic switch to aerobic glycolysis
in thymocytes but not in matureT cells. NaïveT cells take up small
amounts of glucose which is for the most part metabolized to CO2 via
mitochondrial oxidative phosphorylation (OxPhos) for the efﬁcient generation
of ATP. ActivatedT cells and certain thymocyte subsets increase the
expression of the GLUT1 glucose transporter and thus glucose uptake,
and increase glycolytic ﬂux, primarily converting glucose to lactate.
This metabolic switch increases the biosynthetic capacity of theT cells
and is stimulated by antigen receptor signaling (PreTCR, TCR) and
maintained by certain cytokines (IL2). PI3K signaling is required for
this metabolic switch during thymopoiesis but not in peripheral
activatedT cells.
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(Brand et al., 1984; Greiner et al., 1994; Frauwirth et al., 2002;
Wofford et al., 2008).
PI3K AND GLUCOSE METABOLISM IN THE THYMUS
In the thymus discrete subpopulations, e.g., DN4 thymocytes,
engage in rapid growth and robust proliferation. PI3K and Akt
signaling is crucial in allowing these thymocyte subsets to match
their metabolism with metabolic demands (Ciofani and Zuniga-
Pﬂucker, 2005; Juntilla et al., 2007; Kelly et al., 2007; Finlay et al.,
2010). Thus, mice lacking Akt or PDK1 or both PI3Kδ and γ iso-
forms during early thymopoiesis have a profound developmental
block at the DN3/DN4 stage of T cell development(Hinton et al.,
2004;Webb et al., 2005; Swat et al., 2006; Fayard et al., 2007; Juntilla
et al., 2007; Mao et al., 2007). In the absence of PI3K/PDK1/Akt
signaling DN4 thymocytes fail to up-regulate the expression of
the glucose transporter, GLUT1, and also the expression of other
key nutrient receptors for the uptake of amino acids (CD98,
component of the L-amino acid transporter) and iron (transfer-
rin receptor, CD71). Increased provision of these nutrients is a
key requirement for these cells to meet the metabolic demands
of rapid growth and proliferation and PI3K/PDK1/Akt deﬁcient
DN4 thymocytes that fail to do so atrophy and fail to develop
(Juntilla et al., 2007; Kelly et al., 2007). Therefore, in T cells devel-
oping in the thymus, PI3K and Akt signaling is crucial to allow
certain thymocyte subsets to match glucose metabolism with
metabolic demands.
PI3K AND GLUCOSE METABOLISM IN ACTIVATED T CELLS
The metabolic switch to aerobic glycolysis is crucial during the
activation and differentiation of T cells in the periphery. Thus,
limiting glucose availability in activating T cells compromises
TCR induced growth and proliferation and also the expression
of certain effector molecules such as interferon γ (IFNγ; Cham
et al., 2008; Jacobs et al., 2008). The transcription factor c-Myc
is crucial for the metabolic switch in glucose metabolism that
accompanies the activation of naïve T cells (Wang et al., 2011).
Accordingly, deletion of c-Myc in naïve T cells prevents TCR
induced glucose uptake and glycolysis, and activated c-Myc-null
T cells completely fail to grow or proliferate (Trumpp et al., 2001;
Iritani et al., 2002; Dose et al., 2006; Wang et al., 2011). Is PI3K
and Akt signaling also required for the increase in glucose uptake
and glycolysis in TCR activated T cells in the periphery? Cer-
tainly, antigen receptor induced c-Myc expression and glucose
uptake have been attributed to PI3K signaling (Frauwirth et al.,
2002; Grumont et al., 2002; Doughty et al., 2006; Jacobs et al.,
2008; Wang et al., 2011). However, one criticism of these stud-
ies is that they rely on experiments involving the overexpression
of Akt and the use of the PI3K inhibitor LY294002. Overexpres-
sion studies can be difﬁcult to interrupt and while LY294002 was
initially believed to be a highly speciﬁc PI3K inhibitor, and as such
was used in good faith, it has since emerged that this inhibitor is
rather non-speciﬁc. LY294002 potently inhibits a number kinases
other than PI3K, including those with described roles in regulat-
ing T cell growth and proliferation, i.e., mTORC1 and Pim family
kinases (Brunn et al., 1996; Davies et al., 2000; Fox et al., 2005b;
Bain et al., 2007). The importance of these other LY204002 tar-
gets for T cell metabolism can be appreciated by a comparison
of the cellular sizes of PI3K/Akt deﬁcient CD8 cytotoxic T lym-
phocytes (CTL) and wild-type CTL cultured in the presence of
LY294002. While PI3K/Akt deﬁcient CTL are comparable in size
to wild-type CTL, LY294002-treated CTL are substantially smaller
(Cornish et al., 2006; Sinclair et al., 2008; Macintyre et al., 2011).
Therefore, the question as to whether PI3K regulates TCR induced
c-Myc expression has not been satisfactorily investigated to date.
Nevertheless, a comparison of PI3K/Akt and c-Myc deﬁcient T
cells is extremely informative. In contrast to the failure of c-Myc-
null T cells to engage in TCR stimulated growth and proliferation,
PI3K deﬁcient T cells show a relatively mild defect in growth and
proliferation with activated T cells capable of completing numer-
ous divisions, though at a reduced rate (Okkenhaug et al., 2002,
2006). Furthermore, T cells expressing a PDK1 K465E mutant
which have defective TCR stimulatedAkt activity, undergo normal
TCR induced growth and proliferation (Waugh et al., 2009). These
observations coupled to the fact that T cells activated in limiting
concentrations of glucose do show a marked defect in prolifera-
tion argue that TCR induced c-Myc expression, glucose uptake and
glycolysis is not compromised by disruption of PI3K and Akt sig-
naling (Jacobs et al., 2008). More recently, PI3K/Akt independent
glucoseuptake andglycolysis inTCRactivatedTcells has been con-
ﬁrmed using pharmacological inhibitors of PI3Kδ (IC87114) and
Akt (Akti1/2) with substantially greater selectivity than LY294002
(Macintyre et al., 2011). Akti1/2 is particularly selective towardAkt
due to its unique allosteric mechanism of inhibition, binding to
the PH domain of Akt and preventing the PH domain-PI(3,4,5)P3
interaction and the resultant conformational change that is a pre-
requisite for Akt activation (Zhao et al., 2005; Bain et al., 2007).
Both IC87114 and Akti1/2 prevent PI3K/Akt signaling in T cells
while having no effect on TCR induced glucose uptake (Macintyre
et al., 2011). Therefore, it seems clear that PI3K has differential
roles in regulating glucose metabolism in developing thymocytes
in the thymus and mature T cells in the periphery.
Once activated, T cells differentiate into various different effec-
tor T cell subsets depending on the local environment and cytokine
availability. Many of these effector T cell subsets maintain an ele-
vated glycolytic rate in response to cytokine signaling (Macintyre
et al., 2011; Shi et al., 2011). For example, activated CD8 T cells
undergo rapid growth and proliferation in response to interleukin
2 (IL2) as they differentiate into functional CTL. In response to
IL2 signaling CTL maintain high levels of glucose uptake and lac-
tate production indicative of elevated glycolysis (Macintyre et al.,
2011). IL2 also promotes glucose uptake and glycolysis indepen-
dently of PI3K and Akt but a key role has been revealed for PDK1.
Thus, while IC87114 and Akti1/2 have no effect on CTL glucose
uptake, a pronounced decrease is observed following the deletion
of PDK1 using a Cre/loxP strategy (Macintyre et al., 2011). While
PDK1 is responsible for the activation of Akt, it also activates a
number of other members of the AGC kinase family including
protein kinase C (PKC), 70-kDa ribosomal S6 kinase (p70S6K),
90-kDa ribosomal S6 kinase (p90RSK), and serum/glucocorticoid
regulated kinase (SGK; Pearce et al., 2010). However, unlike the
activation of Akt, PDK1 mediated activation of these other AGC
family members are independent of PI3K signaling (Figure 1C).
As members of this kinase family have overlapping substrate
speciﬁcity it is likely that PDK1 dependent, Akt independent
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regulation of glucose metabolism reﬂects functional redundancy
within the AGC family of protein kinases (Brunet et al., 2001;
Zhang et al., 2006; Sapkota et al., 2007).
mTORC1 has described roles in regulating various aspects of
cellular metabolism and given that its activity is independent of
PI3K andAkt in some activated T cell subsets, it remains likely that
mTORC1 is involved in maintaining glucose uptake and glycoly-
sis (unpublished data; Duvel et al., 2010; Macintyre et al., 2011).
Indeed, inhibition of mTORC1 decreases glycolysis in T cells acti-
vatedunderTh17polarizing conditions (Shi et al., 2011). However,
as mTORC1 inhibition also disrupts Th17 differentiation, it is dif-
ﬁcult to interpret whether the effect of rapamycin on glycolysis
is direct or as a result of the differentiation of different T cells.
Therefore, a role for mTORC1 in controlling glycolysis in T cells
has still to be formally demonstrated.
T CELL MIGRATION AND METABOLISM
The expression of adhesion molecules and chemokine receptors
orchestrate the peripheral trafﬁcking of activated T cells. The
p110γ catalytic subunit is the major PI3K isoform in T cells that
promotes PI(3,4,5)P3 signaling in response to chemokines. Thus,
migration to a rangeof chemokines is deﬁcient inp110γ−/− Tcells
and these T cells fail to trafﬁc normally to sites of inﬂammation
(Reif et al., 2004; Smith et al., 2007; Martin et al., 2008; Thomas
et al., 2008). T cell migration and motility are energy demanding
processes and it is tempting to speculate that chemokine recep-
tor signaling might promote T cell glucose metabolism to meet
these energy demands. However, while there is some tentative
data linking chemokine receptor signaling to cell growth and
metabolism in transformed T cells and developing thymocytes
the relationship between chemokine receptor signaling and T cell
metabolism has not been directly studied (Janas et al., 2010; Lo
et al., 2010). Nonetheless, it is worth mentioning that factors that
inﬂuence T cell migration and/or homing, and thus the peripheral
tissue destination of T cells, will affect T cell metabolism, albeit
indirectly, by determining the cytokine environment to which
they are exposed. A comparison of activated T cells responding
to related cytokines IL2 and IL15 illustrates the differential reg-
ulation of T cell metabolism by distinct cytokine environments.
IL2 promotes elevated glucose metabolism and glycolysis while
IL15 does not maintain this metabolic state and T cells responding
to IL15 are smaller with reduced nutrient uptake and glycolysis
(Cornish et al., 2006; Macintyre et al., 2011; unpublished data).
While PI3Kγ controls T cell migration in response to chemokines,
PI3Kδ regulates the repertoire of adhesion and chemokine recep-
tors expressed by activated T cells. PI3Kδ, signaling through Akt
and the Foxo transcription factors, regulates the expression of
key molecules required for T cell homing between the blood and
the lymphoid organs; the adhesion molecule CD62L (also called
L-selectin) and the chemokine receptors CC-chemokine receptor
7 (CCR7) and sphingosine-1-phosphate receptor 1 (S1P1). Dis-
ruption of PI3Kδ/Akt signaling in activated CD8 T cells prevents
the down-regulation of CD62L, CCR7, and S1P1 and these T cells
retain a lymph node trafﬁcking pattern rather than migrating
to non-lymphoid tissues and the sites of inﬂammation (Sinclair
et al., 2008; Waugh et al., 2009; Finlay and Cantrell, 2010; Mac-
intyre et al., 2011). Thus, PI3Kδ deﬁcient T cells activated in
vivo or wild-type T cells activated in mice treated with a PI3Kδ
inhibitor fail to trafﬁc into the periphery to antigenic sites (Jarmin
et al., 2008). Therefore, both PI3Kγ and δ isoforms coordinately
regulate T cell peripheral tissue homing thereby dictating the
cytokine environments encountered and indirectly impacting
upon T cell metabolism.
FINAL REMARK
It has recently become clear that the PI3K/Akt signaling axis is not
the important regulator of glucose uptake and glycolysis in mature
T cells, as initially described. However, disrupting PI3K may in fact
impact upon T cell metabolism through indirect mechanisms, i.e.,
through altering their in vivo trafﬁcking pattern, which will dictate
the cytokines these T cells encounter.
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